Lopez, M <br/><br/>
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.  [electronic resource] 

 -  American journal of clinical oncology  Jun 1990 
 - 204-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199006000-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carmustine--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Palliative Care<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis